Riskpilot← Back to searchSign inGet full accessKARLSLUNDE FYSIOTERAPI ApS
APSActiveCVR 26679893Egedal 1BPhysiotherapy activities · NACE 8695Est. 20021 employees
Revenue 2025
DKK 718K
-6% vs 2024
EBITDA margin
21.7%
+30% vs 2024
Equity ratio
91.6%
Financial strength
Net profit 2025
DKK 117K
+31% vs 2024
| Revenue | DKK 718K | -6% |
| EBITDA | DKK 156K | +30% |
| Net profit | DKK 117K | +31% |
| Total assets | DKK 265K | -81% |
| Equity | DKK 242K | -82% |
| Employees | 1 | — |
Legal name
KARLSLUNDE FYSIOTERAPI ApS
CVR number
26679893
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
1. juli 2002
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at drive fysioterapi klinik og andre beslægtede områder samt handel og finansiering
Address
Egedal 1B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 752 | 970 | 907 | 896 | 967 | 913 | 789 | 811 | 777 | 954 | 798 | 838 | 762 | 718 |
| Staff expenses | -217 | -652 | -442 | -496 | -667 | -537 | -505 | -612 | -587 | -650 | -607 | -487 | -642 | -563 |
| EBITDA | 535 | 318 | 465 | 400 | 300 | 375 | 283 | 199 | 190 | 299 | 190 | 351 | 119 | 156 |
| Depreciation & amort. | -10 | -10 | -5 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 525 | 308 | 460 | 400 | 300 | 375 | 283 | 199 | 190 | 299 | 190 | 351 | 119 | 156 |
| Net financials | -21 | 293 | -774 | -242 | 949 | -317 | -607 | 11 | -198 | 35 | -76 | -33 | -30 | -38 |
| Profit before tax | 505 | 601 | -314 | 158 | 1.248 | 58 | -323 | 210 | -9 | 334 | 115 | 319 | 90 | 117 |
| Tax | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | 506 | 601 | -314 | 158 | 1.248 | 58 | -323 | 210 | -9 | 334 | 115 | 319 | 90 | 117 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.048 | 2.337 | 448 | 667 | 1.826 | 1.371 | 644 | 856 | 860 | 1.211 | 1.211 | 1.307 | 1.392 | 265 |
| Equity | 975 | 1.576 | 62 | 220 | 1.469 | 1.027 | 304 | 514 | 506 | 839 | 954 | 1.273 | 1.362 | 242 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Short-term debt | 72 | 761 | 386 | 447 | 357 | 344 | 340 | 342 | 355 | 371 | 257 | 34 | 30 | 21 |
| Total debt | 72 | 761 | 386 | 447 | 357 | 344 | 340 | 342 | 355 | 371 | 257 | 34 | 30 | 22 |
EBITDA margin
21.7%
This company
15.8%
Market median
+37% vs market
20122025
Equity ratio
91.6%
This company
38.2%
Market median
+140% vs market
20122025
Return on equity
48.4%
This company
18.4%
Market median
+163% vs market
20122025
Net profit margin
16.3%
This company
8.1%
Market median
+101% vs market
20122025
Asset turnover
2.71×
This company
1.12×
Market median
+142% vs market
20122025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AH Chief Executive Officer | Chief Executive Officer | 2002 | — | — |
AJ Management | Management | 2002 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2002 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
HUMEX-RESOURCE HOLDING ApS | Company | 100.0% | 100.0% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HUMEX-RESOURCE HOLDING ApS
KARLSLUNDE FYSIOTERAPI ApS Board members of KARLSLUNDE FYSIOTERAPI ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Annemette Heller | Chief Executive Officer | 0 companies |
| Andries Jan Pieterson | Management | 0 companies |
| Kim Madsen | Chairman | 0 companies |